Response to the Second TNF-α Inhibitor (Adalimumab or Infliximab) after Failing the First One in Refractory Idiopathic Inflammatory Retinal Vascular Leakage.

Arash Maleki,Cristina M. Garcia,Soheila Asgari,Ambika Manhapra,Charles Stephen Foster

Response to the Second TNF-α Inhibitor (Adalimumab or Infliximab) after Failing the First One in Refractory Idiopathic Inflammatory Retinal Vascular Leakage.

2021

Arash Maleki
Cristina M. Garcia
Soheila Asgari
Ambika Manhapra
Charles Stephen Foster

Purpose: To determine the response to the second TNF-α inhibitor (adalimumab and infliximab) after failing the first agent in idiopathic inflammatory retinal vascular leakage.Materials and Methods:...

Keywords:

tnf α inhibitors
Adalimumab
Tumor necrosis factor alpha
Gastroenterology
Infliximab
Refractory
Medicine
Retinal vasculitis
Uveitis
Retinal
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations